Skip to main content

Full Schedule

Full Schedule

  • Friday, October 1, 2021
  • 9:00 AM – 9:25 AM EDT
    Welcome and Opening Session: The State of Clinical Pathways: Journal of Clinical Pathways Benchmarking Survey
  • 9:25 AM – 9:55 AM EDT
    Pathways in Integrated Delivery Systems - Part 1
  • 10:10 AM – 11:10 AM EDT
    Innovation Theater - The Treatment of CLL/SLL and WM with Imbruvica® (non-accredited)
  • 11:25 AM – 11:55 AM EDT
    Ask the Experts
  • 12:10 PM – 12:40 PM EDT
    Pathways in Integrated Delivery Systems - Part 2
  • 12:40 PM – 1:10 PM EDT
    Panel Q&A: Pathways in Integrated Delivery Systems
  • 1:25 PM – 2:10 PM EDT
    Improving Survival and Managing Costs in NSCLC: The Role of Clinical Care Pathways
  • 2:25 PM – 3:10 PM EDT
    Measuring ROI on Standardized Clinical Pathways Utilization
  • 3:25 PM – 4:25 PM EDT
    Innovation Theater - BLENREP for Injection 100mg (non-accredited)
  • 4:40 PM – 5:10 PM EDT
    Ask the Experts
  • 5:25 PM – 6:10 PM EDT
    Utilizing Pathways to Advance Equity in Cancer Care
  • Saturday, October 2, 2021
  • 9:05 AM – 9:50 AM EDT
    Integration of Genetic Testing and Counseling Into Cancer Care
  • 10:05 AM – 11:05 AM EDT
    Innovation Theater- BRUKINSA® (zanubrutinib) for the Treatment of Adult Patients with Waldenström’s Macroglobulinemia (WM) (non-accredited)
  • 11:20 AM – 11:50 PM EDT
    Ask the Experts
  • 12:05 PM – 12:50 PM EDT
    Patient Centered Design of Pathways
  • 1:05 PM – 1:50 PM EDT
    The Utility of Novel Therapies in CLL/SLL Clinical Pathways: Opportunities to Facilitate Treatment Selection and Sequencing
  • 2:05 PM – 2:50 PM EDT
    Pathways to Guide Appropriate and Safe Cancer Pain Management
  • 3:05 PM – 3:35 PM EDT
    Ask the Experts
  • 3:35 PM – 3:50 PM EDT
    Exhibit Hall Break
  • 3:50 PM – 4:35 PM EDT
    Advancing the Management of Small Cell Lung Cancer: Considerations for Clinical Pathways
  • 4:50 PM – 5:35 PM EDT
    Patient Reported Outcomes: Redefining the Way Patients Manage their Symptoms
  • Sunday, October 3, 2021
  • 9:05 AM – 9:50 AM EDT
    Provider & Payer Perspective on Pathway Adoption & Scale
  • 10:05 AM – 11:05 AM EDT
    Innovation Theater - Learn More About an FDA-Approved Treatment for Metastatic Triple-Negative Breast Cancer- (non-accredited)
  • 11:05 AM – 11:20 AM EDT
    Exhibit Hall Break
  • 11:20 AM – 11:50 PM EDT
    Ask the Experts
  • 11:50 AM – 12:05 PM EDT
    Exhibit Hall Break
  • 12:05 PM – 12:50 PM EDT
    Getting on the Path Toward a Successful Oncology Pathways Program
  • 1:05 PM – 1:50 PM EDT
    Urothelial Cancer: The Role of Clinical Care Pathways in Navigating the Expanding Treatment Landscape
  • 2:05 PM – 2:50 PM EDT
    The View on Pathways: The Global Lens
  • 3:05 PM – 4:05 PM EDT
    Innovation Theater - Preliminary Findings From the 2021 Care Pathways Working Group (non-accredited)
  • 4:05 PM – 4:20 PM EDT
    Exhibit Hall Break
  • 4:05 PM – 5:05 PM EDT
    Ask the Experts
  • 4:50 PM – 5:05 PM EDT
    Exhibit Hall Break
  • 5:05 PM – 5:50 PM EDT
    Promoting Evidence-Based and Cost-Effective Treatment of Metastatic Breast Cancer with Clinical Pathways
  • 6:05 PM – 6:50 PM EDT
    Oncology Clinical Pathways Congress Town Hall